Home  /  Resource Library  /  Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

Results of a phase II study investigating tazemetostat for treatment of relapsed follicular lymphoma.